- Home
- SRPT vs MLCO Comparison
SRPT vs MLCO Comparison
Compare SRPT & MLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRPT | MLCO |
|---|---|---|
| Founded | 1980 | 2004 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.5B |
| IPO Year | 1997 | 2006 |
Fundamental Metrics
Financial Performance| Metric | SRPT | MLCO |
|---|---|---|
| Price | $20.46 | $6.01 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 28 | 6 |
| Target Price | ★ $25.76 | $9.42 |
| AVG Volume (30 Days) | ★ 3.1M | 2.4M |
| Earning Date | 02-25-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | $2,413,715,000.00 | ★ $5,061,044,000.00 |
| Revenue This Year | $14.46 | $13.56 |
| Revenue Next Year | N/A | $2.49 |
| P/E Ratio | ★ N/A | $23.62 |
| Revenue Growth | ★ 47.15 | 11.46 |
| 52 Week Low | $10.42 | $4.55 |
| 52 Week High | $120.05 | $10.15 |
Technical Indicators
Market Signals| Indicator | SRPT | MLCO |
|---|---|---|
| Relative Strength Index (RSI) | 43.86 | 28.07 |
| Support Level | $20.10 | $5.90 |
| Resistance Level | $24.68 | $6.53 |
| Average True Range (ATR) | 1.50 | 0.24 |
| MACD | -0.15 | 0.01 |
| Stochastic Oscillator | 6.99 | 12.23 |
Price Performance
Historical ComparisonAbout SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
About MLCO Melco Resorts & Entertainment Limited
Melco Resorts & Entertainment is one of only six licensed casino operators in Macao. It operates Altira, a complex focused on premium customers; City of Dreams, an integrated resort in Cotai serving both mass-market and premium patrons; and Mocha Clubs' electronic gaming machines. The company also has a majority interest in Studio City, which opened in 2015. Outside Macao, Melco owns City of Dreams Manila in the Philippines and City of Dreams Mediterranean in Cyprus. The business mix in terms of adjusted EBITDA was about 81% from Macao, with the rest largely from the Philippines as of 2024.